Steris | STE - Net Income

Stock Price
221.80
Daily Change
-1.72 -0.77%
Monthly
-0.71%
Yearly
-1.42%
Q2 Forecast
220.82

Steris reported $192.9M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
3M USD 653M 76M Mar/2026
Accuray USD 2.54M 6.49M Dec/2024
Avanos Medical USD -1.3M 100K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
CONMED USD 16.74M 13.88M Dec/2025
Cooper Companies USD 130.8M 46.2M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Ecolab USD 563.9M 21.1M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Fortive USD 185.7M 130.7M Dec/2025
Getinge SEK 662M 661M Dec/2024
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Masimo USD 68.3M 168.7M Dec/2025
Olympus JPY 14.17B 6.03B Dec/2025
Orthofix International USD -2.22M 20.57M Dec/2025
Owens Minor USD -56.33M 93.95M Dec/2025
ResMed USD 392.59M 44.06M Dec/2025
Steris USD 192.9M 1000K Dec/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025